About a month ago I reported (here) that democrats in the Senate and House introduced companion bills that would permit generic drug companies to update warning information about the drugs they manufacture, a change that could allow patients to sue the companies for failing to warn about the risks of taking their drugs.
Today, About Lawsuits is reporting (here) that 41 state attorneys general have signed
onto the legislation, known as the “Patient Safety and Generic Labeling
Improvement Act” (S.2295). The National Association of Attorneys Genera
(NAAG) sent a letter of support (pdf) to Senator Leahy and Senator Al Franken, a co-sponsor, on May 11.